RT @v_margar: 4/https://t.co/brrwK1Dvrm *Η long covid μπορει να πληξει ολους κ δεν ειναι αμελητεα https://t.co/rx4H39W7v3 *Δεν εχουμε ακο…
RT @v_margar: 4/https://t.co/brrwK1Dvrm *Η long covid μπορει να πληξει ολους κ δεν ειναι αμελητεα https://t.co/rx4H39W7v3 *Δεν εχουμε ακο…
RT @v_margar: 4/https://t.co/brrwK1Dvrm *Η long covid μπορει να πληξει ολους κ δεν ειναι αμελητεα https://t.co/rx4H39W7v3 *Δεν εχουμε ακο…
RT @v_margar: 4/https://t.co/brrwK1Dvrm *Η long covid μπορει να πληξει ολους κ δεν ειναι αμελητεα https://t.co/rx4H39W7v3 *Δεν εχουμε ακο…
4/https://t.co/brrwK1Dvrm *Η long covid μπορει να πληξει ολους κ δεν ειναι αμελητεα https://t.co/rx4H39W7v3 *Δεν εχουμε ακομη αποτελεσματικη θεραπεια,ειμαστε κοντα ομως. *εχουμε μεχρι στιγμης αποτελεσματικα >90% εμβολια, χωρις φυσικα ολα να ειναι ιδια
Population vulnerability to COVID-19 in Europe: a burden of disease analysis https://t.co/6psarkbOo8
RT @GHWindow: This article illustrates the benefits of a burden of disease approach when making rapid risk assessments, particularly in res…
This article illustrates the benefits of a burden of disease approach when making rapid risk assessments, particularly in response to outbreaks or other research questions. #covid19 @Archpubhealth https://t.co/VgDps9rr9F
@ann_castrel @LizeRaes @sciensano Wij hadden daarnaast gekeken naar de morbiditeitsimpact van ziekten die risicofactoren voor COVID zijn, en dan deed België het beter dan Zweden. Daarnaast bleek ook het % 70-plussers hoger in Zweden dan in België https:
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
Good paper looking at national data on (1) proportion of population aged 70 or above & (2) rate of Years lived with disability #YLD for COVID-19 relevant comorbidity to estimate high risk from COVID-19 #multimorbidity. Data 4 prevention/shielding htt
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
New on https://t.co/8pxKdRV8sp | Population vulnerability to COVID-19 in Europe: a burden of disease analysis | https://t.co/ztA90YLGIL @GMAWyper https://t.co/yOt4Jjvhqj
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
RT @BurdenEU: Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @Sp…
Our paper on population vulnerability to #COVID19 in Europe, taking a #BurdenOfDisease approach has now been published in @SpringerNature @Archpubhealth 🔗https://t.co/DpEKhpwoyS #BurdenEU @COSTprogramme @GMAWyper @IPgrant @ric_assuncao @brechtdv @eilid
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
#BurdenOfDisease of #COVID19 population Vulnerability in Europe estimates #BurdenEU
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
RT @GMAWyper: 1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDis…
1/2 Our #BurdenEU study on population vulnerability to severe #COVID19 illness in Europe, using demographic and #BurdenOfDisease estimates has now been published in @SpringerNat @Archpubhealth @COSTprogramme @BurdenEU @IHME_UW https://t.co/lfDIYye8SG
RT @Archpubhealth: Combining routine statistics such as age distribution (% elderly) and population health status (#burdenofdisease of Non…
RT @drWouterArrazol: Belangrijk om mede het hoge aantal overlijdens tgv COVID 19 in België te verklaren BE scoorde al té slecht op NCD's en…
RT @drWouterArrazol: Belangrijk om mede het hoge aantal overlijdens tgv COVID 19 in België te verklaren BE scoorde al té slecht op NCD's en…
Belangrijk om mede het hoge aantal overlijdens tgv COVID 19 in België te verklaren BE scoorde al té slecht op NCD's en andere gezondheidsindicatoren Er werd gewaarschuwd voor de ernstige en dure gevolgen daarvan. Echter … https://t.co/fqZxla4v9a
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
RT @Archpubhealth: Combining routine statistics such as age distribution (% elderly) and population health status (#burdenofdisease of Non…
Combining routine statistics such as age distribution (% elderly) and population health status (#burdenofdisease of Non Communicable Diseases (#NCDs)) , allows to assess the vulnerability of countries for severe health outcomes from #COVID19 https://t.co/B
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
@FatEmperor if you could overlay vit D levels of the embedded chart, it might go someway to prove why Vit D is so important?
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
@greg_travis Another analysis pointing to other factors than demographics and vulnerability of population perhaps determined the "successful" management of the pandemic spread? https://t.co/BxLdlNHyGu
@FatEmperor I wonder what your thoughts on this study are. Vulnerability doesn't track with severity of the pandemic in individual countries. https://t.co/BxLdlNHyGu
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
RT @brechtdv: Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cu…
Population vulnerability to #COVID19 in #Europe: a #BurdenOfDisease analysis with @GMAWyper @IPgrant @ric_assuncao @sarah_cuschieri @msantric @ElenaPallari @JosePenalvo @SaraMonteiroPi1 @DietrichPlass @sththomsen #BurdenEU @COSTprogramme https://t.co/S